Literature DB >> 12033383

A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers.

Xiaolin Charlie Tang1, Michael J Pikal, Lynne S Taylor.   

Abstract

PURPOSE: To gain insight into the molecular structure of amorphous compounds by investigating hydrogen bonding patterns and strength in a series of structurally related compounds. Seven 1,4-dihydropyridine calcium channel blockers were evaluated.
METHODS: FT-Raman and FT-infrared spectra of the compounds in the crystalline and amorphous states were obtained.
RESULTS: For crystalline compounds, the position of the NH vibration varied considerably. indicating that the strength of hydrogen bonding differs between the different compounds in agreement with published single crystal X-ray data. For the amorphous phases, the NH vibration occurred at approximately the same position for all compounds, suggesting a uniform average hydrogen bonding strength. Somewhat surprisingly, for some compounds, the average hydrogen bond strength in the amorphous state was found to be greater than in the crystalline compound, although for others, it was weaker as anticipated. Hydrogen bonding patterns (acceptor group) varied between the crystalline compounds, but were remarkably consistent in the amorphous compounds; thus the acceptor group in the amorphous phase is not necessarily the same as in the crystalline counterpart.
CONCLUSIONS: Hydrogen bond patterns and strength within a group of chemically related amorphous compounds were found to be very similar, but were different from those in the equivalent group of crystalline substances.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033383     DOI: 10.1023/a:1015147729564

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

Review 1.  Rational design of stable lyophilized protein formulations: some practical advice.

Authors:  J F Carpenter; M J Pikal; B S Chang; T W Randolph
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Binary system of (R)- and (S)-nitrendipine--polymorphism and structure.

Authors:  A Burger; J M Rollinger; P Brüggeller
Journal:  J Pharm Sci       Date:  1997-06       Impact factor: 3.534

3.  Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series.

Authors:  R Fossheim; A Joslyn; A J Solo; E Luchowski; A Rutledge; D J Triggle
Journal:  J Med Chem       Date:  1988-02       Impact factor: 7.446

4.  Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures.

Authors:  L S Taylor; G Zografi
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

5.  Structure of the calcium channel antagonist, nimodipine.

Authors:  S D Wang; L G Herbette; D G Rhodes
Journal:  Acta Crystallogr C       Date:  1989-11-15       Impact factor: 1.172

6.  Crystal structure of the dihydropyridine Ca2+ antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data.

Authors:  R Fossheim
Journal:  J Med Chem       Date:  1986-02       Impact factor: 7.446

7.  Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions.

Authors:  L S Taylor; G Zografi
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

8.  Evidence for solid- and liquid-state interactions in a furosemide-polyvinylpyrrolidone solid dispersion.

Authors:  C Doherty; P York
Journal:  J Pharm Sci       Date:  1987-09       Impact factor: 3.534

9.  Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.

Authors:  A M Triggle; E Shefter; D J Triggle
Journal:  J Med Chem       Date:  1980-12       Impact factor: 7.446

  9 in total
  25 in total

1.  Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture.

Authors:  Alfred C F Rumondor; Håkan Wikström; Bernard Van Eerdenbrugh; Lynne S Taylor
Journal:  AAPS PharmSciTech       Date:  2011-09-17       Impact factor: 3.246

2.  Compositional analysis of low quantities of phase separation in hot-melt-extruded solid dispersions: a combined atomic force microscopy, photothermal fourier-transform infrared microspectroscopy, and localised thermal analysis approach.

Authors:  Sheng Qi; Peter Belton; Kathrin Nollenberger; Andreas Gryczke; Duncan Q M Craig
Journal:  Pharm Res       Date:  2011-05-24       Impact factor: 4.200

3.  An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.

Authors:  Sujinda Keratichewanun; Yasuo Yoshihashi; Narueporn Sutanthavibul; Katsuhide Terada; Jittima Chatchawalsaisin
Journal:  Pharm Res       Date:  2015-02-12       Impact factor: 4.200

4.  Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.

Authors:  Patrick J Marsac; Sheri L Shamblin; Lynne S Taylor
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

5.  Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.

Authors:  Chandan Bhugra; Rama Shmeis; Steven L Krill; Michael J Pikal
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

Review 6.  Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Authors:  Xia Lin; Yang Hu; Lei Liu; Lili Su; Na Li; Jing Yu; Bo Tang; Ziyi Yang
Journal:  Pharm Res       Date:  2018-04-23       Impact factor: 4.200

7.  The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

8.  Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.

Authors:  Shu Li; Yiwei Tian; David S Jones; Gavin P Andrews
Journal:  AAPS PharmSciTech       Date:  2016-01-04       Impact factor: 3.246

9.  Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.

Authors:  Derek S Frank; Adam J Matzger
Journal:  Mol Pharm       Date:  2018-06-20       Impact factor: 4.939

10.  Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.

Authors:  Yanyan Liu; Tianzi Wang; Wenya Ding; Chunliu Dong; Xiaoting Wang; Jianqing Chen; Yanhua Li
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.